» Articles » PMID: 27766672

Validating the 4A's Test in Screening for Delirium in a Culturally Diverse Geriatric Inpatient Population

Overview
Specialties Geriatrics
Psychiatry
Date 2016 Oct 22
PMID 27766672
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To measure the diagnostic accuracy of the 4A's test in screening for delirium in geriatric inpatients from culturally diverse backgrounds.

Methods: A prospective study was conducted with patients admitted to the geriatric and orthogeriatric services of a tertiary teaching hospital. Consenting participants aged 65 years and over were screened for delirium with the 4AT by nursing staff within 72 h of admission. The diagnosis of delirium was made separately by expert assessors, responsible for the participant's clinical care, blinded to the 4AT score, within 30 min of the 4AT assessment using the DSM 5 criteria and the Confusion Assessment Method. Interpreters were used for non-English speaking patients. The Informant Questionnaire for Cognitive Decline in the Elderly was completed by a carer/relative to assess for probable dementia.

Results: A total of 257 participants (mean age 85) were recruited over five months. Delirium was diagnosed in 159 (62%) by the expert assessors and 158 (62%) by the 4AT assessment. A total of 205 participants (80% of total population) had probable dementia. The sensitivity and specificity of the 4AT were 87% and 80%, respectively, in detecting delirium overall, 86% and 71% in people with probable dementia and 91% and 71% for non-English speaking participants. The area under the receiver operating characteristic curve for delirium in the whole population was 0.92, 0.89 in the probable dementia subgroup and 0.90 in non-English speaking participants.

Conclusions: The 4AT is a sensitive and specific screening tool for delirium in geriatric inpatients, including those with probable dementia or who are non-English speaking. Copyright © 2016 John Wiley & Sons, Ltd.

Citing Articles

The 4AT, a rapid delirium detection tool for use in hospice inpatient units: Findings from a validation study.

Arnold E, Finucane A, Taylor S, Spiller J, ORourke S, Spenceley J Palliat Med. 2024; 38(5):535-545.

PMID: 38767241 PMC: 11170929. DOI: 10.1177/02692163241242648.


Delirium and Its Associations with Critical Care Utilizations and Outcomes at the Time of Hospital Discharge in Patients with Acute Brain Injury.

Raquer A, Fong C, Walters A, Souter M, Lele A Medicina (Kaunas). 2024; 60(2).

PMID: 38399591 PMC: 10890045. DOI: 10.3390/medicina60020304.


Preventing Respiratory Viral Illness Invisibly (PRiVII): protocol for a pragmatic cluster randomized trial evaluating far-UVC light devices in long-term care facilities to reduce infections.

Nix H, Meeker S, King C, Andrew M, Davis I, Koto P Trials. 2024; 25(1):88.

PMID: 38279184 PMC: 10811883. DOI: 10.1186/s13063-024-07909-0.


Potentially Inappropriate Prescribing and Potential Prescribing Omissions and Their Association with Adverse Drug Reaction-Related Hospital Admissions.

Brannigan R, Hughes J, Moriarty F, Wallace E, Kirke C, Williams D J Clin Med. 2024; 13(2).

PMID: 38256457 PMC: 10816937. DOI: 10.3390/jcm13020323.


Diagnostic accuracy of the Dutch version of the 4AT for delirium detection in a mixed patient population and setting.

Pouw M, Calf A, Georg R, de Rooij S, Ter Maaten J, van Munster B Aging Clin Exp Res. 2023; 35(8):1705-1710.

PMID: 37285074 PMC: 10363057. DOI: 10.1007/s40520-023-02447-2.